Invenomic Capital Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-39,837
Closed -$10.5M 154
2022
Q2
$10.5M Sell
39,837
-10,415
-21% -$2.68M 0.74% 45
2022
Q1
$12M Buy
50,252
+9,144
+22% +$2.14M 1.29% 17
2021
Q4
$9.44M Buy
41,108
+28,010
+214% +$5.95M 2.02% 11
2021
Q3
$2.62M Buy
+13,098
New +$2.85M 0.85% 43

Other funds holding CI

Invenomic Capital Management's CI Position: Q3 2022 in Review

Invenomic Capital Management sold out of Cigna (CI) in Q3 2022, closing a stake of 39,837 shares — an estimated $10.5M sold.

Invenomic Capital Management first reported a position in CI in Q3 2021 and held it in 4 quarters. The position peaked at $12M in Q1 2022. 1,482 funds tracked by Wall St. Rank hold CI as of Q3 2022.

  • Invenomic Capital Management reported no remaining Cigna position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 39,837 Cigna shares in Q3 2022, an estimated $10.5M.
  • Invenomic Capital Management first reported a position in Cigna in Q3 2021 and held it in 4 quarters.
  • Invenomic Capital Management's Cigna position peaked at $12M in Q1 2022.
  • 1,482 funds tracked by Wall St. Rank held Cigna as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.